These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2342197)

  • 1. The development of liposomes containing interferon alpha for the intravesical therapy of human superficial bladder cancer.
    Frangos DN; Killion JJ; Fan D; Fishbeck R; von Eschenbach AC; Fidler IJ
    J Urol; 1990 Jun; 143(6):1252-6. PubMed ID: 2342197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of antiproliferative activity of interferon alfa against human bladder tumor cell lines by encapsulation of interferon alfa within liposomes.
    Killion JJ; Fan D; Bucana CD; Frangos DN; Price JE; Fidler IJ
    J Natl Cancer Inst; 1989 Sep; 81(18):1387-92. PubMed ID: 2778824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of interferon to intracellular pathways by encapsulation of interferon into multilamellar liposomes is independent of the status of interferon receptors.
    Killion JJ; Fishbeck R; Bar-Eli M; Chernajovsky Y
    Cytokine; 1994 Jul; 6(4):443-9. PubMed ID: 7948753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravesical chemotherapy with interferon in superficial bladder tumors].
    Tanahashi T; Matsumura Y; Yoshimoto J; Tsushima T; Obama T; Akagi T; Ochi J; Hara M; Saegusa M; Ohmori H
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1156-9. PubMed ID: 3105469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical liposomal muramyl tripeptide phosphatidylethanolamine treatment of human bladder carcinoma growing in nude mice.
    Dinney CP; Tanguay S; Bucana CD; Eve BY; Fidler IJ
    J Interferon Cytokine Res; 1995 Jun; 15(6):585-92. PubMed ID: 7553228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior antiproliferative effects mediated by interferon-alpha entrapped in liposomes against a newly established human lung cancer cell line.
    Shin DM; Fidler IJ; Bucana CD; Fan D; Hong WK; Killion JJ
    J Biol Response Mod; 1990 Aug; 9(4):355-60. PubMed ID: 2395001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
    Wu Q; Mahendran R; Esuvaranathan K
    Clin Cancer Res; 2003 Oct; 9(12):4522-8. PubMed ID: 14555526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of liposomes to human bladder tumor epithelial cell lines: implications for an intravesical drug delivery system for the treatment of bladder cancer.
    Johnson JW; Nayar R; Killion JJ; von Eschenbach AC; Fidler IJ
    Sel Cancer Ther; 1989; 5(4):147-55. PubMed ID: 2623380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical interferon alfa in the treatment of superficial bladder cancer.
    Williams RD
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):10-3. PubMed ID: 3057641
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein.
    Benedict WF; Tao Z; Kim CS; Zhang X; Zhou JH; Adam L; McConkey DJ; Papageorgiou A; Munsell M; Philopena J; Engler H; Demers W; Maneval DC; Dinney CP; Connor RJ
    Mol Ther; 2004 Sep; 10(3):525-32. PubMed ID: 15336652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.
    Konety BR; Lavelle JP; Pirtskalaishvili G; Dhir R; Meyers SA; Nguyen TS; Hershberger P; Shurin MR; Johnson CS; Trump DL; Zeidel ML; Getzenberg RH
    J Urol; 2001 Jan; 165(1):253-8. PubMed ID: 11125420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of intracavitary interferon-alpha-2b in the prophylactic treatment of patients with superficial bladder cancer.
    Moltó L; Alvarez-Mon M; Carballido J; Olivier C; Gimeno F; Manzano L
    Cancer; 1995 Jun; 75(11):2720-6. PubMed ID: 7743476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic intracavitary treatment with interferon alpha increases interferon gamma production by peripheral blood mononuclear cells in patients with superficial transitional cell carcinoma of the bladder.
    Moltó L; Carballido J; Manzano L; Reyes E; Olivier C; Alvarez-Mon M
    Br J Cancer; 1997; 75(12):1849-53. PubMed ID: 9192993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG.
    Haaff EO; Catalona WJ; Ratliff TL
    J Urol; 1986 Oct; 136(4):970-4. PubMed ID: 3489840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical bacille Calmette-Guérin induces the antiangiogenic chemokine interferon-inducible protein 10.
    Poppas DP; Pavlovich CP; Folkman J; Voest EE; Chen X; Luster AD; O'Donnell MA
    Urology; 1998 Aug; 52(2):268-75; discussion 275-6. PubMed ID: 9697793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel insights into the mechanism of action of intravesical immunomodulators.
    Mitropoulos DN
    In Vivo; 2005; 19(3):611-21. PubMed ID: 15875784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of intravesical delivery with Syn3 potentiates interferon-alpha2b gene therapy for superficial bladder cancer.
    Nagabhushan TL; Maneval DC; Benedict WF; Wen SF; Ihnat PM; Engler H; Connor RJ
    Cytokine Growth Factor Rev; 2007; 18(5-6):389-94. PubMed ID: 17692556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of mouse bladder tumor proliferation by alpha difluoromethylornithine and interferon in vitro and in vivo.
    Bahnson RR; Ratliff TL
    J Urol; 1988 Jun; 139(6):1367-71. PubMed ID: 3131549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value.
    de Reijke TM; de Boer EC; Kurth KH; Schamhart DH
    J Urol; 1996 Feb; 155(2):477-82. PubMed ID: 8558640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.